859 related articles for article (PubMed ID: 26277040)
1. Update on Hidradenitis Suppurative (Part II): Treatment.
Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with hidradenitis suppurativa.
Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
Moyano B; Clemente A; Marín-Jiménez I; Martorell A
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
Lam J; Krakowski AC; Friedlander SF
Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
[TBL] [Abstract][Full Text] [Related]
5. Biologics for hidradenitis suppurativa: an update.
Włodarek K; Ponikowska M; Matusiak Ł; Szepietowski JC
Immunotherapy; 2019 Jan; 11(1):45-59. PubMed ID: 30702012
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
Bassas-Vila J; González Lama Y
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
[TBL] [Abstract][Full Text] [Related]
8. An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity.
Martorell A; García-Martínez FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodriguez J; Salgado L; Vilarrasa E
Actas Dermosifiliogr; 2015 Nov; 106(9):703-15. PubMed ID: 26254550
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
10. LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.
Tchernev G
Georgian Med News; 2023; (340-341):297-300. PubMed ID: 37805915
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hidradenitis suppurativa with biologic medications.
Lee RA; Eisen DB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of acne inversa].
Schneider-Burrus S; Arpa E; Kors C; Stavermann T; Sabat R; Kokolakis G
Hautarzt; 2018 Jan; 69(1):58-63. PubMed ID: 29234829
[TBL] [Abstract][Full Text] [Related]
13. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC
Expert Rev Clin Immunol; 2016 Oct; 12(10):1015-26. PubMed ID: 27531618
[TBL] [Abstract][Full Text] [Related]
15. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
[TBL] [Abstract][Full Text] [Related]
16. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
Theut Riis P; Thorlacius LR; Jemec GB
Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
[TBL] [Abstract][Full Text] [Related]
18. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.
Maarouf M; Clark AK; Lee DE; Shi VY
J Dermatolog Treat; 2018 Aug; 29(5):441-449. PubMed ID: 29098911
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
Megna M; Bettoli V; Chimenti S; Chiricozzi A; Naldi L; Virgili A; Girolomoni G; Monfrecola G
G Ital Dermatol Venereol; 2015 Dec; 150(6):731-9. PubMed ID: 26513043
[TBL] [Abstract][Full Text] [Related]
20. Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
van der Zee HH; Gulliver WP
Dermatol Clin; 2016 Jan; 34(1):91-6. PubMed ID: 26617362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]